WILMINGTON, Del. - The U.S. Food and Drug Administration (FDA) has granted approval to AstraZeneca (NASDAQ:AZN)'s CALQUENCE® ...
A team of researchers has developed a new biomaterial with high potential in in the treatment of bone lesions or minimal residual disease in multiple myeloma patients. The findings showcase a ...
Houston Texans wide receiver Tank Dell is expected to have surgery on his left knee to begin the process of returning to the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback